Advanced search
Publication Cover
Cell Cycle Volume 20, 2021 - Issue 9
Submit an article Journal homepage
536
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

LncRNA PSMG3AS1 promotes proliferation of non-small cell lung cancer cells by sponging miR-613 to upregulate SphK1

Weiyu Shena Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo City, Zhejiang Province, P.R. ChinaCorrespondence[email protected] [email protected]
View further author information
,
Xunyu Hongb Department of Internal Medicine, Ningbo Women and Children’s Hospital, Ningbo City, Zhejiang Province, P.R. ChinaView further author information
,
Chenghua Jina Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo City, Zhejiang Province, P.R. ChinaView further author information
&
Yong Xia Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo City, Zhejiang Province, P.R. ChinaCorrespondence[email protected] [email protected]
View further author information
Pages 829-838 | Received 03 Feb 2020, Accepted 04 Mar 2021, Published online: 14 Apr 2021

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. .
  • Reddy KP, Kong CY, Hyle EP, et al. Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States. JAMA Intern Med. 2017;177(11):1613–1621. .
  • Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res. 2015;4(4):327–338.
  • Couraud S, Zalcman G, Milleron B, et al. Lung cancer in never smokers–a review. Eur J Cancer. 2012;48(9):1299–1311. .
  • Pallis AG, Syrigos KN. Lung cancer in never smokers: disease characteristics and risk factors. Crit Rev Oncol Hematol. 2013;88(3):494–503.
  • Cheng L, Alexander RE, MacLennan GT, et al. Molecular pathology of lung cancer: key to personalized medicine. Mod Pathol. 2012;25(3):347–369.
  • Cooper WA, Lam DCL, O’Toole SA, et al. Molecular biology of lung cancer. J Thorac Dis. 2013;5(Suppl 5):S479–S490. .
  • Chan BA. Hughes B G M. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res. 2015;4(1):36–54.
  • Janku F, Stewart DJ, Kurzrock R. Targeted therapy in non-small-cell lung cancer—is it becoming a reality? Nat Rev Clin Oncol. 2010;7(7):401–414.
  • Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703–719.
  • Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–1109.
  • Cui Y, Fan Y, Zhao G, et al. Novel lncRNA PSMG3-AS1 functions as a miR‑143‑3p sponge to increase the proliferation and migration of breast cancer cells. Oncol Rep. 2020;43(1):229–239. .
  • Yu H, Duan P, Zhu H, et al. miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1. Am J Transl Res. 2017;9(3):1213–1221.
  • Li D, Li DQ, Liu D, et al. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer. Cell Oncol (Dordr). 2016;39(2):139–147. .
  • Jalali S, Bhartiya D, Lalwani MK, et al. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PloS One. 2013;8(2):e53823. .
  • Li J, Guan HY, Gong LY, et al. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res. 2008;14(21):6996–7003. .
  • Song L, Xiong H, Li J, et al. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Clin Cancer Res. 2011;17(7):1839–1849. .
  • Gachechiladze M, Tichý T, Kolek V, et al. Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine. Oncol Lett. 2019;18(2):1259–1266. .
  • Ito H, Yoshida K, Murakami M, et al. Heterogeneous sphingosine-1-phosphate lyase gene expression and its regulatory mechanism in human lung cancer cell. lines. Biochim Biophys Acta. 2011;1811(3):119–128. doi:10.1016/j.bbalip.2010.12.005.
  • Fan Z, Jiang H, Wang Z, et al. Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-β1 by attenuating the upregulation of SphK1. Oncol Rep. 2016;36(2):1016–1022. .
  • Pulkoski-Gross MJ, Obeid LM. Molecular mechanisms of regulation of sphingosine kinase1. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(11):1413–1422.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.